D Moreno Sánchez, J Medina Asensio, F Colina Ruiz-Delgado, R Campos Cantero, L Crespo Rincón, A Belda Serna
{"title":"卡咪唑治疗后急性亚块状胆汁淤积性肝炎。一个新病例的报告和文献综述]。","authors":"D Moreno Sánchez, J Medina Asensio, F Colina Ruiz-Delgado, R Campos Cantero, L Crespo Rincón, A Belda Serna","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Carbimazole, an antithyroid agent of the thioimidazole group, can induce unpredictable liver alterations, presumably by hypersensitivity. We describe the case of a hyperthyroid woman who suffered acute submassive cholestatic hepatitis in the course of treatment with this drug. We also review the other seven cases of carbimazole hepatotoxicity previously communicated in the literature.</p>","PeriodicalId":76457,"journal":{"name":"Revista espanola de las enfermedades del aparato digestivo","volume":"76 3","pages":"273-6"},"PeriodicalIF":0.0000,"publicationDate":"1989-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Acute submassive cholestatic hepatitis after treatment with carbimazole. Presentation of a new case and review of the literature].\",\"authors\":\"D Moreno Sánchez, J Medina Asensio, F Colina Ruiz-Delgado, R Campos Cantero, L Crespo Rincón, A Belda Serna\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Carbimazole, an antithyroid agent of the thioimidazole group, can induce unpredictable liver alterations, presumably by hypersensitivity. We describe the case of a hyperthyroid woman who suffered acute submassive cholestatic hepatitis in the course of treatment with this drug. We also review the other seven cases of carbimazole hepatotoxicity previously communicated in the literature.</p>\",\"PeriodicalId\":76457,\"journal\":{\"name\":\"Revista espanola de las enfermedades del aparato digestivo\",\"volume\":\"76 3\",\"pages\":\"273-6\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1989-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista espanola de las enfermedades del aparato digestivo\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista espanola de las enfermedades del aparato digestivo","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
[Acute submassive cholestatic hepatitis after treatment with carbimazole. Presentation of a new case and review of the literature].
Carbimazole, an antithyroid agent of the thioimidazole group, can induce unpredictable liver alterations, presumably by hypersensitivity. We describe the case of a hyperthyroid woman who suffered acute submassive cholestatic hepatitis in the course of treatment with this drug. We also review the other seven cases of carbimazole hepatotoxicity previously communicated in the literature.